DEK and breast carcinoma: Given that DEK has a known role in driving glycolysis [17] and we recently reported enriched gene expression of glycolysis and cholesterol biosynthesis pathways in RON overexpressing breast cancer cells [18], we hypothesize that RON and DEK dysregulation impacts cellular metabolism to promote breast cancer metastasis/recurrence.